Iritero

Iritero Indications/Uses

irinotecan

Manufacturer:

Amarox
Full Prescribing Info
Indications/Uses
IRITERO is indicated for the treatment of patients with advanced colorectal cancer: In combination with 5-fluorouracil and Folinic acid in patients without prior chemotherapy for advanced disease; As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.
Irinotecan combination with Cisplatin is indicated for treatment of patients with small cell lung cancer.
Strictly follow the recommended dosage unless directed otherwise by the physician.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in